Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030
- PMID: 26042651
- PMCID: PMC4584771
Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030
Abstract
Background: Melanoma incidence rates have continued to increase in the United States, and risk behaviors remain high. Melanoma is responsible for the most skin cancer deaths, with about 9,000 persons dying from it each year.
Methods: CDC analyzed current (2011) melanoma incidence and mortality data, and projected melanoma incidence, mortality, and the cost of treating newly diagnosed melanomas through 2030. Finally, CDC estimated the potential melanoma cases and costs averted through 2030 if a comprehensive skin cancer prevention program was implemented in the United States.
Results: In 2011, the melanoma incidence rate was 19.7 per 100,000, and the death rate was 2.7 per 100,000. Incidence rates are projected to increase for white males and females through 2019. Death rates are projected to remain stable. The annual cost of treating newly diagnosed melanomas was estimated to increase from $457 million in 2011 to $1.6 billion in 2030. Implementation of a comprehensive skin cancer prevention program was estimated to avert 230,000 melanoma cases and $2.7 billion in initial year treatment costs from 2020 through 2030.
Conclusions: If additional prevention efforts are not undertaken, the number of melanoma cases is projected to increase over the next 15 years, with accompanying increases in health care costs. Much of this morbidity, mortality, and health care cost can be prevented.
Implications for public health practice: Substantial reductions in melanoma incidence, mortality, and cost can be achieved if evidence-based comprehensive interventions that reduce ultraviolet (UV) radiation exposure and increase sun protection are fully implemented and sustained.
Figures
Similar articles
-
Update on the incidence and mortality from melanoma in the United States.J Am Acad Dermatol. 1999 Jan;40(1):35-42. doi: 10.1016/s0190-9622(99)70562-1. J Am Acad Dermatol. 1999. PMID: 9922010
-
The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S133-43. doi: 10.1016/j.jaad.2011.04.036. J Am Acad Dermatol. 2011. PMID: 22018062
-
Melanoma burden and recent trends among non-Hispanic whites aged 15-49years, United States.Prev Med. 2016 Oct;91:294-298. doi: 10.1016/j.ypmed.2016.08.032. Epub 2016 Aug 24. Prev Med. 2016. PMID: 27565055 Free PMC article.
-
Epidemiology of malignant melanoma.Surg Clin North Am. 2003 Feb;83(1):1-29. doi: 10.1016/s0039-6109(02)00092-0. Surg Clin North Am. 2003. PMID: 12691448 Review.
-
Cutaneous melanoma.Cancer Surv. 1994;19-20:219-40. Cancer Surv. 1994. PMID: 7534627 Review.
Cited by
-
Impact of Dermoscopy Training on Diagnostic Accuracy, and Its Association With Biopsy and Referral Patterns Among Primary Care Providers: A Retrospective and Prospective Educational Intervention Study.J Prim Care Community Health. 2024 Jan-Dec;15:21501319241296625. doi: 10.1177/21501319241296625. J Prim Care Community Health. 2024. PMID: 39498620 Free PMC article.
-
Trends in Melanoma Mortality in Serbia: A 22-Year Population-Based Study.Iran J Public Health. 2024 Apr;53(4):828-836. doi: 10.18502/ijph.v53i4.15559. Iran J Public Health. 2024. PMID: 39444477 Free PMC article.
-
Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database.Front Pharmacol. 2024 Sep 9;15:1413154. doi: 10.3389/fphar.2024.1413154. eCollection 2024. Front Pharmacol. 2024. PMID: 39314755 Free PMC article.
-
Long-Read MDM4 Sequencing Reveals Aberrant Isoform Landscape in Metastatic Melanomas.Int J Mol Sci. 2024 Aug 30;25(17):9415. doi: 10.3390/ijms25179415. Int J Mol Sci. 2024. PMID: 39273363 Free PMC article.
-
Designing a Culturally Relevant Digital Skin Cancer Prevention Intervention for Hispanic Individuals: Qualitative Exploration.JMIR Form Res. 2024 Sep 12;8:e56939. doi: 10.2196/56939. JMIR Form Res. 2024. PMID: 39265165 Free PMC article.
References
-
- Ekwueme DU, Guy GP, Li C, Rim SH, Parelkar P, Chen SC. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity—United States, 2000 to 2006. J Am Acad Dermatol. 2011;65:S133–S143. - PubMed
-
- Gilchrest BA, Eller MS, Geller AC, Yaar M. Mechanisms of disease: the pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341–8. - PubMed
-
- Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 1993;3:395–401. - PubMed
-
- CDC. Preventing skin cancer: findings of the Task Force on Community Preventive Services on reducing exposure to ultraviolet light. MMWR Recomm Rep. 2003;52(RR-15) - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
